Your Benefits
– “State of the Art” insights related to DPI technology –
– Innovations in device, excipient and manufacturing technology –
– Networking, business opportunities, know-how transfer –
Registration
Be invited to INHALATION INSIGHTS, a Dry Powder Inhalation Technology Symposium at the Ritz-Carlton Kuala Lumpur. Register to the one-day event.
Constantia Flexibles is the world’s fourth largest producer of flexible packaging. Based on the guiding principle of “People, Passion, Packaging,” around 7,500 employees manufacture tailor-made packaging solutions at 32 sites in 18 countries. Many international companies and local market leaders from the food and pharma industries choose the sustainable and innovative products of Constantia Flexibles.
Focusing on anti-counterfeiting solutions, consumer safety and sustainable packaging Constantia Flexibles Pharma Division supports pharmaceutical manufacturers worldwide to meet their main challenges. Production sites operated in Austria, Germany, Italy, Spain, Vietnam, the UK and Belgium make Constantia Flexibles Pharma Division the world’s second largest flexible packaging manufacturer for the pharmaceutical industry.
Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. The company offers extensive services related to process development and the design of GMP-compliant production conditions. Harro Höfliger’s experts conducting process capability analyses of active ingredient containing substances under real conditions and support customers in recipe optimization or the manufacturing of stability samples. They have special expertise in the processing of powder materials for inhalative and solid administration forms. The systematically structured portfolio of upscalable test and production machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Harro Höfliger covers all phases from the laboratory stage to high-performance production.
MEGGLE
Experts in Excipients
MEGGLE Excipients & Technology is a global leader in manufacturing lactose for the pharmaceutical industry. Supporting supply chain security with manufacturing facilities in Europe and North America, MEGGLE offers a broad product portfolio of lactose excipients for oral / inhaled drug delivery applications, including co-processed technologies & tailor made services.
Our broad product portfolio, multiple manufacturing locations, technical centers in major markets and innovative technologies make MEGGLE the preferred partner for pharmaceutical product manufacturers.
MEGGLE E&T products:
- Lactose monohydrate
- Anhydrous Lactose
- Co-Processed Excipients
- Lactose for Inhalation
- Lactose for lyophilization and parentral applications
- Tailor-made lactose products
MEGGLE E&T Services:
- Spray drying
- Co-Processing
- Agglomeration
- Product Customization
Merxin
Generic Medical Devices Made Easy
Merxin is a generic medical device development and supply company. We specialise in off-the-shelf generic devices. Our expertise is the supply of inhaler, ready to be filled with clients’ formulations. In addition to supplying devices, Merxin supports its clients with formulating, testing, manufacturing, clinical and filing expertise.
Merxin can supply you with:
MRX001: a generic 505j opportunity multidose blister inhaler (cf fluticasone/salmeterol)
MRX002: a see-through pMDI cannister
MRX003: a generic 505j opportunity capsule inhaler (cf tiotropium)
MRX004: a softmist inhaler; 505j opportunity for tiotropium/olodaterol. Also useful for life cycle management and new molecules.
#Reduce Cost, #Reduce Risk, #Increase Success
Find us on:
www.merxin.com
LinkedIn: https://www.linkedin.com/company/merxin-ltd/
Twitter: @MRXdevices
Contact us at:
Merxin Ltd
the KLIC
1 Innovation Way
King’s Lyn PE30 5BY, UK
+44 (0)1223 787 300
info@merxin.com
Nanopharm
YOUR RESPIRATORY DRUG DELIVERY SPECIALISTS
We are the world’s leading provider of orally inhaled and nasal drug product design and development services. We enable the seamless translation of pre-clinical development through to clinical manufacture of OINDPs through our unique processing technologies and formulation development tools. Our integrated development services in materials characterisation, formulation development and inhaled biopharmaceutics aids successful product development of OINDPs by understanding how material properties and processing conditions influence product functionality. We are the market leaders in providing bespoke solutions to the development of OINDPs. Our technology platforms for advanced materials characterisation, formulation & device development, together with in silico modelling of OINDP in vivo behaviour, is acknowledged as cutting edge and market leading.
Special Guest – Professor Dr. Wong
Professor Dr Wong Tin Wui obtained his PhD degree from the National University of Singapore in 1999. His research areas are primarily focused on particle/scaffold design for oral, transdermal and pulmonary drug delivery. He has published over 90 peer reviewed articles. He is the editorial board member of Asian Journal of Pharmaceutical Sciences, associate editor of Drug Design, Development and Therapy, and regional editor of Current Drug Delivery. Professor Wong is the advisory board member/outstanding scientists jury for several international conference awards (eg. Maurice-Marie Janot Award and Lecture, Tefarco Innova-PharmaTech Scientist Award). He is the founder, chair and honorary advisory board member of PharmaTech – an International Conference and Exhibition on Pharmaceutical, Nutraceutical and Cosmeceutical Technology.
SPONSORS
